TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31155969

Group type: EXPERIMENTAL
Intervention: Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Task-Specific Training (TST)
Number of subjects: 44
Study: 31639320

Group type: EXPERIMENTAL
Intervention: Maximum nasal feedback condition
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Minimum nasal feedback condition
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baseline feedback conditions
Number of subjects: 20
Study: 28109298

Group type: EXPERIMENTAL
Intervention: Intravenous G-CSF followed by mPBMC infusion
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Intravenous G-CSF followed by mPBMC infusion at 7 months (T7 group)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Intravenous G-CSF followed by mPBMC infusion at 1 month (T1 group)
Number of subjects: 57

Group type: COMPARATOR
Intervention: mPBMC infusion
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 57
Study: 25426510

Group type: EXPERIMENTAL
Intervention: PAP trial (4 maximal 10-m swims at 1-minute intervals before a 6-minute rest)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control trial (standard swim warm-up followed by a 6-minute rest and maximal 100-m freestyle swim effort)
Number of subjects: 30
Study: 24554302

Group type: EXPERIMENTAL
Intervention: Prulifloxacin (600 mg once a week for 12 weeks)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Fosfomycin (3 g once a week for 12 weeks)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Prulifloxacin and Fosfomycin (both groups)
Number of subjects: 152
Study: 21636230

Group type: EXPERIMENTAL
Intervention: Combination therapy with clarithromycin (200mg/day) and S-carboxymethylcysteine (1500mg/day) for 12 weeks
Number of subjects: 425

Group type: COMPARATOR
Intervention: Monotherapy with clarithromycin (200mg/day) for 12 weeks
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Combination therapy with clarithromycin and S-carboxymethylcysteine
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Both groups (combination and monotherapy)
Number of subjects: 425
Study: 19489132

Group type: EXPERIMENTAL
Intervention: 200 mcg HFA-BDP bid for 12 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: 400 mcg CFC-BDP bid for 12 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: HFA-BDP
Number of subjects: 38
Study: 17407649

Group type: EXPERIMENTAL
Intervention: DPP-4 inhibitors as monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DPP-4 inhibitors as add-on therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DPP-4 inhibitors
Number of subjects: 0
Study: 16874208

Group type: EXPERIMENTAL
Intervention: Vacuum-assisted closure therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Modern dressings
Number of subjects: 65
Study: 12780372

Group type: EXPERIMENTAL
Intervention: Computer-generated tailored advice plus callback telephone counselling
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Computer-generated tailored advice only
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Control condition (untailored self-help materials)
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Callback telephone counselling
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Computer-generated tailored advice
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: NRT (nicotine replacement therapy)
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Sustained abstinence
Number of subjects: 1578
Study: 10224730

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CB)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Psychodynamic-interpersonal therapy (PI)
Number of subjects: 116
Study: 8936558

Group type: EXPERIMENTAL
Intervention: 100 mg of vitamin E per day
Number of subjects: 21

Group type: COMPARATOR
Intervention: 1 g of vitamin C per day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 1826239

Group type: EXPERIMENTAL
Intervention: Proinsulin
Number of subjects: 15
Study: 6193665

Group type: EXPERIMENTAL
Intervention: 10 ml of dextran 1, 15% administered intravenously two minutes before infusion of dextran 70 or dextran 40
Number of subjects: 29252

Group type: EXPERIMENTAL
Intervention: 10 ml of dextran 1, 15%
Number of subjects: 29252
Study: 31046075

Group type: EXPERIMENTAL
Intervention: DMEK
Number of subjects: 38
Study: 28421567

Group type: EXPERIMENTAL
Intervention: Oral treatment (28 tablets of 1000 µg cyanocobalamin per month)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intramuscular treatment (four weekly injections of 1000 µg hydroxocobalamin)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Oral treatment
Number of subjects: 37

Group type: COMPARATOR
Intervention: Intramuscular treatment
Number of subjects: 37
Study: 25041291

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 23793444

Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation (PVI) with radiofrequency or cryoenergy
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: LA pressure
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: LA volume index
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: AF type
Number of subjects: 205
Study: 21882997

Group type: EXPERIMENTAL
Intervention: Internet-based behavioral weight loss program with weekly group meetings delivered entirely by online synchronous chats
Number of subjects: 323

Group type: COMPARATOR
Intervention: Internet-based behavioral weight loss program with weekly group meetings delivered by a combination of online chats plus monthly in-person group sessions
Number of subjects: 323
Study: 18387865

Group type: EXPERIMENTAL
Intervention: Continuous wound instillation with ropivacaine 0.2%
Number of subjects: 17

Group type: COMPARATOR
Intervention: Isotonic saline (control group)
Number of subjects: 17
Study: 17022844

Group type: EXPERIMENTAL
Intervention: Ropinirole 0.25‐4.0 mg once daily 1‐3 hours before bedtime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12630974

Group type: EXPERIMENTAL
Intervention: Insulin Aspart (IAsp)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Human Insulin (HI)
Number of subjects: 17
Study: 10866717

Group type: EXPERIMENTAL
Intervention: 8% sevoflurane
Number of subjects: 14

Group type: COMPARATOR
Intervention: 3% sevoflurane
Number of subjects: 14
Study: 9114180

Group type: EXPERIMENTAL
Intervention: Vancomycin or metronidazole for active C. difficile diarrhea
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Sequential episodes of C. difficile diarrhea
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Risk factors for RCDD
Number of subjects: 124
Study: 1549227

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (average doses: 5 to 10, 10 to 20, and 20 to 40 units per muscle)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Botulinum toxin
Number of subjects: 17
Study: 4044293

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 12
Study: 31179007

Group type: EXPERIMENTAL
Intervention: 3-day antibiotic treatment
Number of subjects: 1101

Group type: COMPARATOR
Intervention: 3-day placebo treatment
Number of subjects: 1101

Group type: EXPERIMENTAL
Intervention: Parents' education levels
Number of subjects: 1101
Study: 28977390

Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 26775230

Group type: EXPERIMENTAL
Intervention: Patterned electrical neuromuscular stimulation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 15
Study: 25300507

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verteporfin photodynamic therapy (vPDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation (no treatment)
Number of subjects: 0
Study: 22508360

Group type: EXPERIMENTAL
Intervention: 25% (w/v) honey solution
Number of subjects: 101

Group type: COMPARATOR
Intervention: 0.3% ofloxacin
Number of subjects: 101
Study: 19854494

Group type: EXPERIMENTAL
Intervention: DUR-8E
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Wolf Viper
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: FlexVision
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Olympus URF-P5
Number of subjects: 175
Study: 18005909

Group type: EXPERIMENTAL
Intervention: EPs (30 drops, 1.5 mL, three times a day for a maximum of 10 days)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo (three times a day for a maximum of 10 days)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: EPs
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Adverse events in EPs group
Number of subjects: 103
Study: 16118171

Group type: EXPERIMENTAL
Intervention: Radiography followed by a short MR imaging examination
Number of subjects: 500

Group type: COMPARATOR
Intervention: Radiography alone
Number of subjects: 500
Study: 11230472

Group type: EXPERIMENTAL
Intervention: suramin plus hydrocortisone
Number of subjects: 460

Group type: COMPARATOR
Intervention: placebo plus hydrocortisone
Number of subjects: 460
Study: 9563220

Group type: EXPERIMENTAL
Intervention: metronidazole (400 mg t.i.d. for 7 days)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: secnidazole (500 mg t.i.d. for 5 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: metronidazole
Number of subjects: 32

Group type: COMPARATOR
Intervention: secnidazole
Number of subjects: 32
Study: 7996065

Group type: EXPERIMENTAL
Intervention: L-asparaginase
Number of subjects: 136

Group type: COMPARATOR
Intervention: High dose methylprednisolone
Number of subjects: 136

Group type: COMPARATOR
Intervention: Conventional dose steroids
Number of subjects: 136
Study: 3131798

Group type: EXPERIMENTAL
Intervention: sabeluzole (R 58735)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 31644389

Group type: EXPERIMENTAL
Intervention: Telehealth intervention (BASICS)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Face-to-face intervention (BASICS)
Number of subjects: 51
Study: 29778364

Group type: EXPERIMENTAL
Intervention: Cilostazol (100 mg twice a day)
Number of subjects: 1534

Group type: COMPARATOR
Intervention: Aspirin (100 mg once a day)
Number of subjects: 1534

Group type: EXPERIMENTAL
Intervention: Cilostazol plus probucol (250 mg twice a day)
Number of subjects: 1534

Group type: COMPARATOR
Intervention: Aspirin plus probucol
Number of subjects: 1534
Study: 28142074

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) treatment on scan 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26226536

Group type: EXPERIMENTAL
Intervention: Proactive QL intervention with up to an 8-week supply of free nicotine replacement therapy
Number of subjects: 1298

Group type: COMPARATOR
Intervention: Reactive QL intervention with a 2-week supply of nicotine replacement therapy
Number of subjects: 1298
Study: 22814361

Group type: EXPERIMENTAL
Intervention: Claims data for fecal occult blood testing
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Claims data for colonoscopy
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Claims data for sigmoidoscopy
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Over- and underdocumentations of colonoscopy and fecal occult blood testing
Number of subjects: 400
Study: 21907619

Group type: EXPERIMENTAL
Intervention: Small-sided game warm-up
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Leg-press warm-up
Number of subjects: 10

Group type: COMPARATOR
Intervention: Team-sport warm-up
Number of subjects: 10
Study: 18276664

Group type: EXPERIMENTAL
Intervention: Structured group education programme for six hours delivered in the community by trained healthcare professional educators
Number of subjects: 824

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Structured group education programme
Number of subjects: 824
Study: 17044457

Group type: EXPERIMENTAL
Intervention: Tacrolimus + Fluconazole (100-200 mg/day for one week)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tacrolimus (stable dosage)
Number of subjects: 23
Study: 12850655

Group type: EXPERIMENTAL
Intervention: Disease management intervention by Depression Clinical Specialists (DCSs)
Number of subjects: 13
Study: 10379287

Group type: EXPERIMENTAL
Intervention: EPi‐Guide
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Guidor
Number of subjects: 40
Study: 8638341

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg twice daily for seven days postoperatively
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no NSAID treatment)
Number of subjects: 50
Study: 1676530

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 16

Group type: COMPARATOR
Intervention: Flumazenil
Number of subjects: 16
Study: 6223651

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nebulized ipratropium bromide
Number of subjects: 12
Study: 28943191

Group type: EXPERIMENTAL
Intervention: Temporary bilateral uterine artery occlusion and myomectomy (Group A)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Laparoscopic myomectomy only (Group B)
Number of subjects: 64
Study: 26624250

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS) for 20 minutes per day for 4 weeks at an incident intensity of 30 mW/cm².
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham transducer (control group).
Number of subjects: 10
Study: 25057105

Group type: EXPERIMENTAL
Intervention: 5 g/day of Arthrospira platensis (Asp)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo of equal protein content and energy
Number of subjects: 73
Study: 23083772

Group type: EXPERIMENTAL
Intervention: AMG 145 (doses of 7, 21, 70, 210, or 420 mg SC; 21 or 420 mg IV; 14 or 35 mg QW ×6; 140 or 280 mg Q2W ×3; 420 mg every 4 weeks ×2)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: AMG 145 (140 mg Q2W ×3)
Number of subjects: 113
Study: 20179322

Group type: EXPERIMENTAL
Intervention: C.E.R.A. administered via intravenous (IV) route once every 2 weeks (Q2W)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C.E.R.A. administered via subcutaneous (SC) route once every 4 weeks (Q4W)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C.E.R.A. administration (IV or SC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dosing schedule, administration route, and study type
Number of subjects: 0
Study: 18990320

Group type: EXPERIMENTAL
Intervention: 50 mg of DHEA daily for 12 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 15931623

Group type: EXPERIMENTAL
Intervention: Intravenous cyanocobalamin every 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous cyanocobalamin every 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (1 mg intravenous cyanocobalamin every 28 days)
Number of subjects: 0
Study: 12939214

Group type: EXPERIMENTAL
Intervention: Prothrombotic risk factors
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Underlying predisposing conditions
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Factor V, protein C, protein S, elevated Lp(a)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Combination of a prothrombotic risk factor with an underlying condition
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Increased Lp(a)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Protein C deficiency
Number of subjects: 149
Study: 10483818

Group type: EXPERIMENTAL
Intervention: ECOG scale
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: KPS scale
Number of subjects: 100
Study: 9179835

Group type: EXPERIMENTAL
Intervention: Decision support using the hand-held patient-oriented insulin regimen optimizer (POIRO)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No decision support (control)
Number of subjects: 6
Study: 1684416

Group type: EXPERIMENTAL
Intervention: Formulas with marine oil (0.2% or 0.4%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control formulas (identical to commercially available formulas)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marine oil feeding
Number of subjects: 0
Study: 7049878

Group type: EXPERIMENTAL
Intervention: Erythromycin combined with bromhexine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Erythromycin alone (implied control)
Number of subjects: 22
Study: 6367528

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (AMCA) 1 g t.i.d. 24 h prior to and following intradermal injection of anti-IgE
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29511019

Group type: EXPERIMENTAL
Intervention: Extra virgin coconut oil
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Unsalted butter
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil
Number of subjects: 94
Study: 29952500

Group type: EXPERIMENTAL
Intervention: Electrosurgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Scalpel or Scissors
Number of subjects: 80
Study: 24918567

Group type: EXPERIMENTAL
Intervention: Ingenol mebutate 0.015% gel
Number of subjects: 329

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 329
Study: 23010094

Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate (250 mg, weekly intramuscular)
Number of subjects: 657

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 657
Study: 21077560

Group type: EXPERIMENTAL
Intervention: Motorcycle lighting with daytime running lights (DRLs)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Age of the driver of the other vehicle
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 75
Study: 18707726

Group type: EXPERIMENTAL
Intervention: Cranberry juice cocktail (3 times daily)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Cranberry juice cocktail (breakfast) then placebo (lunch and dinner)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo (3 times daily)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Cranberry juice (multiple daily dosing)
Number of subjects: 188
Study: 15918389

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg kg(‐1))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study: 12692453

Group type: EXPERIMENTAL
Intervention: Breathing Bear
Number of subjects: 72

Group type: COMPARATOR
Intervention: Non-Breathing Bear
Number of subjects: 72
Study: 10573193

Group type: EXPERIMENTAL
Intervention: Clomipramine at 0.5 to 1.0 mg/kg twice daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Clomipramine at 1.0 to 2.0 mg/kg twice daily
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Behavioural therapy
Number of subjects: 49
Study: 8916636

Group type: EXPERIMENTAL
Intervention: Participants whose depression symptoms decreased from baseline to the end of treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants whose depression symptoms increased from baseline to the end of treatment
Number of subjects: 0
Study: 1985673

Group type: EXPERIMENTAL
Intervention: Teaching at hospital A
Number of subjects: 190

Group type: COMPARATOR
Intervention: Teaching at hospitals B, C, and D
Number of subjects: 190
Study: 6218577

Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (standard antimicrobial therapy)
Number of subjects: 97
Study: 31806944

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) with 2000 pulses; 2.5 bars; 5 Hz, 7 mins, performed twice a week for five weeks (10 sessions) and stabilization training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham rESWT and stabilization training
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) with stabilization training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham rESWT with stabilization training
Number of subjects: 40
Study: 29262276

Group type: EXPERIMENTAL
Intervention: Endoscopic third ventriculostomy with choroid plexus cauterization (ETV‐CPC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ventriculoperitoneal shunting
Number of subjects: 100
Study: 25929812

Group type: EXPERIMENTAL
Intervention: Cognitive Interview (CI)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Standard Interview (SI)
Number of subjects: 125
Study: 23499523

Group type: EXPERIMENTAL
Intervention: Echocardiographically-guided pacing mode (Mode 2)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Factory pacing mode (Mode 1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both modes (Mode 1 and Mode 2)
Number of subjects: 22
Study: 21616171

Group type: EXPERIMENTAL
Intervention: Carer education intervention (two home-delivered education sessions based on academic detailing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 19632665

Group type: EXPERIMENTAL
Intervention: 10 units of intramuscular oxytocin (group 1)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: 600 microg oral misoprostol (group 2)
Number of subjects: 251

Group type: COMPARATOR
Intervention: No additional medication (group 3)
Number of subjects: 251
Study: 17020910

Group type: EXPERIMENTAL
Intervention: High-dose diazepam (15 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-dose diazepam (5 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 14763723

Group type: EXPERIMENTAL
Intervention: Early full weight bearing (Group 2)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Early partial weight bearing (Group 1)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study: 11559268

Group type: EXPERIMENTAL
Intervention: Exercise (aerobic training, 3.4 times/week for 18 weeks)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise (resistance training, 2.5 times/week for 15 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise groups
Number of subjects: 14
Study: 9394987

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of gold sodium thiomalate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20